Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking a 213% Potential Upside in the Biotech Space 1 July 2025
Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring the 93% Upside Potential in Biotech’s Visionary Play 1 July 2025
Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating a Pivotal Year with 5.70% Revenue Growth 1 July 2025
ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 24% Upside Potential with Robust Revenue Growth 1 July 2025
Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals 134.63% Potential Upside 1 July 2025
Kestra Medical Technologies (KMTS) Stock Analysis: A 65.86% Upside Potential in the Healthcare Sector 1 July 2025
Opko Health, Inc. (OPK) Stock Analysis: Exploring a 202% Upside Potential Despite Current Challenges 1 July 2025
Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Contender with a 92% Potential Upside 1 July 2025
10x Genomics, Inc. (TXG) Stock Analysis: Evaluating Growth Potential with a 12.93% Upside 1 July 2025
Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating the Uncharted Waters of a $1.02 Billion Bioelectric Medicine Innovator 1 July 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Biotech Player with an 83% Potential Upside 1 July 2025
Harrow, Inc. (HROW) Stock Analysis: Eyeing an 86% Upside Potential in the Healthcare Sector 1 July 2025
Janux Therapeutics, Inc. (JANX) Stock Analysis: Unraveling a Potential 264% Upside in Immunotherapy 1 July 2025
Ascentage Pharma (AAPG): Investor Outlook Amid Significant Revenue Growth and Market Challenges 1 July 2025
BioLife Solutions, Inc. (BLFS) Stock Analysis: Unveiling a Potential 44.95% Upside for Investors 1 July 2025
IDEAYA Biosciences (IDYA) Stock Analysis: Uncovering a 142.99% Potential Upside in Biotechnology 1 July 2025
XP Factory: Escape Hunt Delivers Record Margins as Boom Battle Bar Fuels Top-Line Growth (Video) 10 December 2025
Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video) 10 December 2025
NB Private Equity Partners: Buybacks, Exits and a Quiet Rebound Investors Are Missing (Video) 24 November 2025
Verge Technologies: Why SentientDB Is Mission-Critical in a Multi-Cloud World (Video) 24 November 2025
Cavendish Plc Market Resilience, Deep Value, and a 7.5% Yield That’s Hard to Ignore (Video) 24 November 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential 2 June 2025
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook with a 7.54% Dividend Yield and Strategic Retail Focus 1 January 2026
Smithson Investment Trust PLC O (SSON.L): A Steady Contender with Solid Market Position 1 January 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Uncovering Potential with a 64% Upside 1 January 2026
